The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of pembrolizumab (MK-3475) in metastatic cutaneous squamous cell carcinoma: An updated analysis.
 
Melinda Lynne Yushak
No Relationships to Disclose
 
David H. Lawson
No Relationships to Disclose
 
Monica Goings
No Relationships to Disclose
 
Marjorie Mckellar
No Relationships to Disclose
 
Necia Maynard
No Relationships to Disclose
 
Kristin Sieja Woodruff
No Relationships to Disclose
 
Caroline Gorgoglione
No Relationships to Disclose
 
Stephanie McBrien
No Relationships to Disclose
 
Keith A. Delman
No Relationships to Disclose
 
Michael C. Lowe
No Relationships to Disclose
 
Ragini Reiney Kudchadkar
Honoraria - Array BioPharma; Bristol-Myers Squibb
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Novartis
Research Funding - Merck (Inst); Regeneron (Inst)